The SAFE Purchase Agreement: A Founder's Section-by-Section Guide
Most founders learn quickly that a SAFE is not just one document. The SAFE itself — the "simple agreement for future equity" — is the instrument that converts into stock in a future round. But before anyone signs a SAFE, a smart company almost always signs a SAFE Purchase Agreement: the wrapper contract that says who is buying, how much, at what closing, under what representations, and on what legal terms.
Founders often treat the Purchase Agreement as boilerplate and rush to sign the SAFE. That's a mistake. The Purchase Agreement is where every dispute about "what did we actually agree to" gets resolved. Every ambiguity you leave in it — the maximum raise, the definition of accredited investor, the governing law, the ability to add additional purchasers — becomes a fight later.
This guide walks the standard SAFE Purchase Agreement from top to bottom in plain English. It is written for founders who have a term sheet or a lead investor and are about to close a SAFE round, and who want to understand what they are actually signing before they hand it to counsel.
The opening block does three simple things: identifies the company, identifies the purchasers on Exhibit A, and sets the total ceiling of the round (the "Maximum Amount"). This is the single most important number in the whole document. Everything downstream — dilution, option pool math, the pitch to your next lead — sits on top of it.
Get the Maximum Amount right the first time. Founders routinely set the ceiling too low, hit it in the first two weeks, and then have to sign an amendment to keep taking checks. Every amendment costs legal fees and, worse, gives every purchaser a reason to reopen the terms. If you think you can raise $1.5M, put the Maximum Amount at $2.0M. If you think you can raise $2.5M, put it at $3.0M. Nothing forces you to sell to the ceiling; nothing punishes you for leaving room.
Section 1.1 attaches the actual SAFE as Exhibit B. Read Exhibit B before you read anything else, because the economics live there — valuation cap, discount, most-favored-nation clause, pro-rata rights, conversion mechanics. The Purchase Agreement is the wrapper; the SAFE is the money.
The Purchase Agreement almost always contemplates an Initial Closing and a series of Additional Closings. This is the "rolling close" mechanic and it is the single biggest reason founders sign a Purchase Agreement instead of just signing SAFEs one-off with each investor.
Add new purchasers next week, next month, and three months from now on the exact same terms, without re-negotiating.
Update Exhibit A each time to reflect who bought what, without amending the underlying agreement.
The cap is the Maximum Amount. Every Additional Closing must fit under it. As long as you stay under the ceiling, you can keep adding purchasers by simply issuing them a new SAFE and updating Exhibit A.
Keep a clean, dated, running copy of Exhibit A. It becomes the source of truth for your cap table, your 409A, your data room, and eventually the schedule of exceptions in your Series A stock purchase agreement.
Section 1.2(b) is the mechanical closing. The company delivers a signed SAFE; the purchaser wires or delivers a check for the amount opposite their name on Exhibit A. Founder rule: do not countersign the SAFE until the wire has cleared. A signed SAFE with no money is a promise you have to chase and, if the investor never funds, a document you have to formally rescind.
Section 2 is where the company (you) makes a series of factual statements to the purchaser about the company's state as of the Initial Closing. Every rep is a small risk allocation. If a rep is wrong, the purchaser has a claim.
You state that the company is a properly incorporated Delaware corporation in good standing. Two-minute homework: log into Delaware's Division of Corporations and confirm current good standing, and make sure your annual franchise tax is paid. If good standing has lapsed, fix it before the closing, not after.
This is the most litigated rep in any early-stage financing. You are stating, on the record, exactly how many shares of Common Stock are authorized, how many are outstanding, how many are reserved for the option plan, how many options are granted and how many remain available, and — critically — that there are no other outstanding rights to acquire equity.
Founders get in trouble here in three ways: forgotten side letters (a verbal promise to a cofounder or an advisor that "we'll figure out shares later" is an outstanding right — paper it before you sign); undocumented option grants (if your board approved options but never executed the grant agreements, the rep is inaccurate); and old SAFEs or convertible notes (if you already have SAFEs outstanding from a previous close, they are securities convertible into common and must be disclosed).
Your safest posture is to attach a Capitalization Schedule as an exhibit and have this section refer to it. It moves the specifics out of the body of the agreement and into one place you can update.
You state the company has the corporate power to sign the agreement and that signing it doesn't violate the bylaws, a material law, or a material contract. This is why you need a board consent approving the SAFE offering and, if your charter or a prior investor agreement requires it, a stockholder consent as well. Do not sign a SAFE Purchase Agreement before those consents are executed.
You state that entering into the agreement will not violate any law, trigger acceleration under a material contract, or create a lien on your assets. If you have a venture debt facility, a bank line, or an SBA loan, read those documents carefully — some of them require lender consent for any equity issuance.
You state that no third-party consents are required other than your own corporate approvals, standard securities filings, and the future corporate approvals needed to authorize the preferred stock the SAFE will convert into. That last piece is important: the SAFE does not itself authorize preferred stock. You promise to authorize it later, at conversion. If your charter doesn't have enough authorized shares to accommodate the conversion, you should know it's coming.
You state that the company owns or has rights to the IP it needs to run the business, without infringing others. This rep is where undocumented IP assignments blow up companies. Every founder, every early employee, every contractor who wrote a line of code or designed a logo should have signed a PIIA assigning all work-for-hire IP to the company. If they haven't, this rep is inaccurate. Fix it first.
You state there is no pending or (to your knowledge) threatened litigation against the company or its officers. This is a "to knowledge" rep. If a former employee has sent a demand letter alleging wrongful termination, that's a threatened claim and it should be disclosed on a Disclosure Schedule carve-out. Undisclosed threatened claims are exactly the kind of thing that causes a purchaser to unwind a financing.
You state no governmental consent is needed other than standard securities filings — principally the Form D filing under Regulation D of the Securities Act. Founders forget the Form D. It must be filed within 15 days of the first sale of securities. Miss it in enough states and you can lose the ability to raise under Rule 506 in the future.
You state the company is not in violation of its charter, bylaws, or material contracts. Read your existing agreements. Some venture debt facilities and enterprise customer contracts have change-of-control or covenant-of-solvency provisions that a SAFE round can indirectly trip.
You state your assets are free and clear of liens, except for statutory tax liens and ordinary-course items. If you have a UCC-1 filed by a factoring company or an old lender, you must disclose it.
You state, assuming the purchasers' reps in Section 3 are accurate, that the SAFE offering qualifies for an exemption from Securities Act registration. This is the reason Section 3 (accredited investor status) exists. If your purchaser is not actually accredited and you didn't take reasonable steps to verify it, the exemption fails and the offering is unregistered — a serious problem.
Section 3 flips the direction. Now the purchasers are making reps to you. This is why you do not accept a SAFE from someone who refuses to sign the Purchase Agreement — the reps in Section 3 are what keep your securities exemption alive.
Each purchaser confirms they have the legal power to sign. Simple for individuals; harder for entities. If a purchaser signs through an LLC or a trust, get evidence of authority — an operating agreement excerpt or a trustee certification.
Every purchaser represents they are an accredited investor within Rule 501 of Regulation D. Under the current definition, an individual qualifies by net worth over $1M excluding primary residence (individually or with spouse), income over $200,000 individually or $300,000 jointly for the last two years with the same expectation this year, or holding a Series 7, 65, or 82 license in good standing. Entities qualify under separate tests (total assets over $5M, all equity owners accredited, etc.).
Founder practice: use a short accredited investor questionnaire as a signature exhibit and keep it on file. It gives you documentary evidence of "reasonable steps to verify" if the SEC ever asks.
The purchaser acknowledges they had a chance to ask questions and did not ask for a private placement memorandum. This rep exists so a purchaser cannot later sue you for failing to hand over a formal PPM. It does not, however, allow you to lie or omit material facts in the pitch. The safest posture is to send every purchaser your standard investor update deck and any material risks in writing.
The purchaser acknowledges the SAFE and any securities issued on conversion are "restricted securities" and cannot be resold except under registration or an exemption. This is standard and enforceable. It also gives you the legal basis to put a restrictive legend on the SAFE and on any stock issued on its conversion.
The purchaser acknowledges there is no public market for your securities. Obvious, but required.
The purchaser represents they can bear the economic risk of losing the entire investment. Founders should read this as a reminder: if you are taking money from someone whose life will fall apart if they lose it, you should probably not take that money, no matter what they represent on paper.
The purchaser confirms they were not solicited through a public advertisement or a broker who was paid a commission. This is the anti–general-solicitation rep. It protects your Rule 506(b) exemption. If you have publicly advertised your raise on X, on Product Hunt, or on a "we're raising" landing page, you have likely blown 506(b) and you need to be raising under 506(c) — which requires you to actually verify accreditation, not just accept a representation.
The last section is what lawyers call "boilerplate." Do not skip it. Every clause matters.
The agreement binds successors and assigns. If a purchaser dies, gets acquired, or transfers their interest, the new party steps into the same shoes.
This template picks New York law and New York courts. Many SAFE Purchase Agreements pick Delaware or California. The choice matters. Litigating a securities dispute in New York from your kitchen in San Francisco is expensive. If you can, negotiate governing law to match either your state of incorporation (Delaware) or your principal place of business.
The agreement can be signed in counterparts, by fax, or by DocuSign. Standard. This is the clause that lets you close the round without ever being in the same room as the purchaser.
Section headings are for convenience only and don't govern interpretation.
Every well-drafted Purchase Agreement includes a notices section. Make sure the notice addresses match reality. If you moved offices, update them. A notice that gets ignored because it went to the wrong address can be deemed delivered.
Standard clause: the agreement can only be amended in a writing signed by the company and by purchasers holding a specified percentage (typically a majority) of the SAFEs. Read this carefully. If a single purchaser has veto power because of a percentage threshold, you need to know that before you sign.
The agreement, the SAFE, and their exhibits are the entire agreement and supersede any prior discussions. This is why a side letter promising a purchaser something not in the SAFE is legally weak — and why any promise a founder makes verbally during a raise ("you'll get a board seat," "you'll get pro-rata," "you'll get MFN") needs to be reduced to writing and either put in a side letter or built into the SAFE itself.
The prevailing party in any litigation is entitled to reasonable attorneys' fees. Founders sometimes negotiate this out. If you leave it in, understand that a losing suit against an investor can cost you their legal bill on top of your own.
The Exhibits are the operational core of the Purchase Agreement. They are also where mistakes hide.
This is the list of every purchaser, the amount they are purchasing, and (often) the date they closed. Update it at every Additional Closing. Keep a version-controlled copy in your data room. Common errors: names not matching legal names (an investor's entity is "Smith Family Investments LLC," not "John Smith"); amounts not matching the wire that actually cleared; missing signature blocks for entity purchasers.
This is the actual SAFE instrument. Read it separately, with the same care you read the Purchase Agreement. Verify the valuation cap, the discount rate (if any), the most-favored-nation clause, and the pro-rata rights.
Standard practice: attach a short questionnaire that each purchaser completes and signs, confirming which prong of the accredited investor definition they satisfy. It gives you the documentary record that supports the Section 2.11 exemption.
Before you sign the SAFE Purchase Agreement, run this list: board consent signed and dated approving the SAFE offering, the Maximum Amount, and the form of SAFE; stockholder consent if required by your charter or a prior investor agreement; cap table reconciled and attached as an exhibit or Capitalization Schedule; disclosure schedule with any exceptions to the Section 2 reps written down and attached; accredited investor questionnaires signed by every purchaser; wire instructions confirmed and re-confirmed (never send wire instructions by email without a voice or in-person confirmation); Form D calendar reminder filed within 15 days of the first closing; state blue-sky filings filed in every state where a purchaser resides on the required timeline; PIIA coverage on every founder, employee, and contractor; and a data room copy with the countersigned Purchase Agreement, every SAFE, and the current Exhibit A saved together in one folder.
A SAFE Purchase Agreement is not a term sheet. It's not a stock purchase agreement. It doesn't grant board seats, doesn't create a preferred stock class, and doesn't give the purchaser voting rights. It is a contract to sell a SAFE, and the SAFE is a contract to issue equity later.
That two-step structure is what makes SAFEs fast — you don't need to authorize preferred stock, you don't need to negotiate protective provisions, you don't need to renumber your charter. It is also what makes them dangerous when founders raise too much on too many caps: at the priced round, all of those SAFEs convert at once and the founder's ownership can move dramatically overnight.
Model the conversion before you close. Take the Maximum Amount, the caps, the discounts, and the projected priced-round valuation, and run the pro forma. If the conversion of your SAFE stack takes you below the ownership you need to still lead the company, either reduce the Maximum Amount, raise the caps, or shift some of the round into a priced structure.
The SAFE Purchase Agreement is a short document that does an enormous amount of work. It sets the ceiling of your raise, unlocks the rolling close, papers the reps that keep your securities exemption alive, and defines how you and your investors resolve disputes when — not if — they arise.
Founders who read it once, negotiate the two or three clauses that actually matter (Maximum Amount, governing law, and any amendment threshold), and then execute cleanly get the entire benefit of the SAFE structure: fast money, minimal legal cost, and a clean record when the priced round comes. Founders who sign it blind get a document they don't understand, a cap table they can't reconcile, and — occasionally — a securities problem that costs more to fix than the entire round raised.
